MedPath

A confirmation study for the improvement effect of skin quality by the test food consumptio

Not Applicable
Conditions
ot applicable
Registration Number
JPRN-UMIN000037734
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects who 1)have habit to consume yogurt more than 3 days a week. 2)have habit to consume beverages include lactic acid bacteria and/or bifidobacteria more than 2 days a week. 3)have habit to consume vitamin supplements more than 3 days a week. 4)regularly use gastrointestinal drugs or female hormone. 5)have taken antibiotics within a month. 6)are currently being treated or who plan to be treated for pollen allergy. 7)repeat constipation and diarrhea. 8)declared their defecate habit as >= 3 times and/or <= 9 times in a week. 9)have severe past and/or current medical history. 10)are being treated or have medical histories uterine fibroid and/or ovarian cyst. 11)are pregnant or are lactating. 12)have allergy to medicine and/or food. 13)are atopic dermatitis, contact dermatitis and/or skin hypersensitivity. 14)have rough skin because of pollen allergy. 15)have birthmark, scar and/or acne on the part of measurement. 16)have excess suntan and/or who stay outside long time. 17)plan to go traveling abroad and/or to go swimming in the sea during this test period. 18)are receiving special care of face and/or arm in the service. 19)have excess irregular meal cycle and/or have irregular life rhythm. 20)are excessive smoker and/or heavy drinkers of alcohol. 21)are participating, who have participated within 4 weeks and/or who plan to participate after informed consent, in other clinical test. 22)donated over 200mL blood and/or blood components within a month. 23)donated over 400mL blood within the last 4 months. 24)will be collected over 800mL blood and/or blood components when the sampling amounts within the last 12 months are adding to the planned sampling amounts of this study. 25)Others they have been determined ineligible by investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
*Moisture content of the horny layer *Transepidermal water loss
Secondary Outcome Measures
NameTimeMethod
*QOL questionnaire *Stool tests (Physical and chemical analysis, Microbiota of gut) *Days of defecation *Defecation frequency *Fecal properties *Urine test * Incidence of adverse events and of side effects
© Copyright 2025. All Rights Reserved by MedPath